BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17901236)

  • 1. Transgenic overexpression of pregnancy-associated plasma protein-A increases the somatic growth and skeletal muscle mass in mice.
    Rehage M; Mohan S; Wergedal JE; Bonafede B; Tran K; Hou D; Phang D; Kumar A; Qin X
    Endocrinology; 2007 Dec; 148(12):6176-85. PubMed ID: 17901236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism.
    Kumar A; Mohan S; Newton J; Rehage M; Tran K; Baylink DJ; Qin X
    J Biol Chem; 2005 Nov; 280(45):37782-9. PubMed ID: 16115888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo.
    Qin X; Wergedal JE; Rehage M; Tran K; Newton J; Lam P; Baylink DJ; Mohan S
    Endocrinology; 2006 Dec; 147(12):5653-61. PubMed ID: 16946002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic overexpression of pregnancy-associated plasma protein-A in skeletal muscle of mice increases myofiber size and central nucleation in sedentary muscle and promotes muscle regeneration in the injured muscle.
    Deb C; Li B; Baylink DJ; Xing W; Zhang W; Chen M; Wergedal JE; Mohan S; Qin X
    Growth Horm IGF Res; 2012 Oct; 22(5):173-9. PubMed ID: 22709655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of insulin-like-growth factors diminished the anabolic effects of pregnancy-associated plasma protein-A (PAPP-A) on bone in mice.
    Phang D; Rehage M; Bonafede B; Hou D; Xing W; Mohan S; Wergedal JE; Qin X
    Growth Horm IGF Res; 2010 Jun; 20(3):192-200. PubMed ID: 20144555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
    Resch ZT; Simari RD; Conover CA
    Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs.
    Boldt HB; Conover CA
    Growth Horm IGF Res; 2007 Feb; 17(1):10-8. PubMed ID: 17218136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced contractile force generation by artificial skeletal muscle tissues using IGF-I gene-engineered myoblast cells.
    Sato M; Ito A; Kawabe Y; Nagamori E; Kamihira M
    J Biosci Bioeng; 2011 Sep; 112(3):273-8. PubMed ID: 21646045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo.
    Boldt HB; Conover CA
    Endocrinology; 2011 Apr; 152(4):1470-8. PubMed ID: 21303951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IGF system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-associated plasma protein-A proteolytic activity in rat vertebral cell cultures: stimulation by dexamethasone--a potential mechanism for glucocorticoid regulation of osteoprogenitor proliferation and differentiation.
    Jia D; Heersche JN
    J Cell Physiol; 2005 Sep; 204(3):848-58. PubMed ID: 15754336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice.
    Miller BS; Bronk JT; Nishiyama T; Yamagiwa H; Srivastava A; Bolander ME; Conover CA
    J Endocrinol; 2007 Mar; 192(3):505-13. PubMed ID: 17332520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts.
    Bunn RC; Green LD; Overgaard MT; Oxvig C; Fowlkes JL
    Biochem Biophys Res Commun; 2004 Dec; 325(3):698-706. PubMed ID: 15541345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro.
    Byun D; Mohan S; Yoo M; Sexton C; Baylink DJ; Qin X
    J Clin Endocrinol Metab; 2001 Feb; 86(2):847-54. PubMed ID: 11158056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
    Sun IY; Overgaard MT; Oxvig C; Giudice LC
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A.
    Bale LK; Conover CA
    J Endocrinol; 2005 Aug; 186(2):325-31. PubMed ID: 16079258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation.
    Giudice LC; Conover CA; Bale L; Faessen GH; Ilg K; Sun I; Imani B; Suen LF; Irwin JC; Christiansen M; Overgaard MT; Oxvig C
    J Clin Endocrinol Metab; 2002 May; 87(5):2359-66. PubMed ID: 11994388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.